Related references
Note: Only part of the references are listed.Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li et al.
CANCER RESEARCH (2018)
Autocrine Adenosine Regulates Tumor Polyfunctional CD73(+)CD4(+) Effector T Cells Devoid of Immune Checkpoints
Nicolas Gourdin et al.
CANCER RESEARCH (2018)
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells
Debangshu Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
Extracellular purines, purinergic receptors and tumor growth
F. Di Virgilio et al.
ONCOGENE (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
Farhad Jadidi-Niaragh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Extracellular ATP and adenosine: The Yin and Yang in immune responses?
M. M. Faas et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Martin Turcotte et al.
CANCER RESEARCH (2017)
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Arabella Young et al.
CANCER RESEARCH (2017)
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy
Julia Reinhardt et al.
CANCER RESEARCH (2017)
Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment
Yunlu Dai et al.
CHEMICAL SOCIETY REVIEWS (2017)
CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages
Patrick S. Murphy et al.
CELL DEATH AND DIFFERENTIATION (2017)
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Bruno G. Leclerc et al.
CLINICAL CANCER RESEARCH (2016)
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
Deepak Mittal et al.
CANCER RESEARCH (2016)
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor
Shin Foong Ngiow et al.
CANCER RESEARCH (2016)
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne et al.
CANCER RESEARCH (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier
Do-Geun Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CD73 Inhibition Shifts Cardiac Macrophage Polarization toward a Microbicidal Phenotype and Ameliorates the Outcome of Experimental Chagas Cardiomyopathy
Nicolas Eric Ponce et al.
JOURNAL OF IMMUNOLOGY (2016)
CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors
Lokesh A. Kalekar et al.
NATURE IMMUNOLOGY (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Mechanisms of modulation of cytokine release by human cord blood monocytes exposed to high concentrations of caffeine
Raul Chavez-Valdez et al.
PEDIATRIC RESEARCH (2016)
Regulation of the T Cell Response by CD39
Maisa C. Takenaka et al.
TRENDS IN IMMUNOLOGY (2016)
CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
Zhen-Hu Ren et al.
ONCOLOGY LETTERS (2016)
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression
Claudia Sorrentino et al.
ONCOTARGET (2016)
CD73-adenosine reduces immune responses and survival in ovarian cancer patients
Pierre-Olivier Gaudreau et al.
ONCOIMMUNOLOGY (2016)
Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg)
F. Figueiro et al.
ONCOIMMUNOLOGY (2016)
Targeting CD73 in the tumor microenvironment with MEDI9447
Carl M. Hay et al.
ONCOIMMUNOLOGY (2016)
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
Itsaso Montalban del Barrio et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation
Elizabeth A. Vecchio et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Luca Antonioli et al.
TRENDS IN CANCER (2016)
Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy
Changyou Zhan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3
Sima Hajiahmadi et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2015)
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
Hyun-Bae Jie et al.
CANCER RESEARCH (2015)
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
Martin Turcotte et al.
CANCER RESEARCH (2015)
CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression
Maria Rosa Bono et al.
FEBS LETTERS (2015)
CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells
Felipe Flores-Santibanez et al.
IMMUNOLOGY (2015)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death
J. S. Long et al.
ONCOGENE (2015)
The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma
Bin Zhang et al.
TUMOR BIOLOGY (2015)
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
Claudia Sorrentino et al.
ONCOTARGET (2015)
Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia
Nashwa Khairat Abousamra et al.
LEUKEMIA & LYMPHOMA (2015)
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
Jeremy Bastid et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Nanoparticles containing insoluble drug for cancer therapy
Shutao Guo et al.
BIOTECHNOLOGY ADVANCES (2014)
Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells
Debanjana Chatterjee et al.
BLOOD (2014)
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
Shilpak Chatterjee et al.
CANCER RESEARCH (2014)
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal et al.
CANCER RESEARCH (2014)
NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer
Li Xiong et al.
CELL AND TISSUE RESEARCH (2014)
Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer
Bertrand Allard et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Dysfunctional CD39POS Regulatory T Cells and Aberrant Control of T-Helper Type 17 Cells in Autoimmune Hepatitis
Charlotte R. Grant et al.
HEPATOLOGY (2014)
The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor
Tian-zhu Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors
Jie Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A Novel Mechanism of B Cell-Mediated Immune Suppression through CD73 Expression and Adenosine Production
Hiroaki Kaku et al.
JOURNAL OF IMMUNOLOGY (2014)
Targeting Cancer-Derived Adenosine: New Therapeutic Approaches
Arabella Young et al.
CANCER DISCOVERY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Adenosine production by human B cells and B cell-mediated suppression of activated T cells
Zenichiro Saze et al.
BLOOD (2013)
Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer
Patrick J. Schuler et al.
CLINICAL CANCER RESEARCH (2013)
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Bertrand Allard et al.
CLINICAL CANCER RESEARCH (2013)
Identification of sulfonic acids as efficient ecto-5′-nucleotidase inhibitors
Jamshed Iqbal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Recent advances in delivery of drug-nucleic acid combinations for cancer treatment
Jing Li et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
Mikkel G. Terp et al.
JOURNAL OF IMMUNOLOGY (2013)
Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages
Balazs Koscso et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis
Qing Yang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A2B adenosine receptor blockade inhibits growth of prostate cancer cells
Qiang Wei et al.
PURINERGIC SIGNALLING (2013)
Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
Raffaella Iannone et al.
NEOPLASIA (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
H. Wang et al.
BRITISH JOURNAL OF CANCER (2012)
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
Adam T. Waickman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
Crystal Structure of a Soluble Form of Human CD73 with Ecto-5′-Nucleotidase Activity
Dominic P. H. M. Heuts et al.
CHEMBIOCHEM (2012)
Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Luca Antonioli et al.
CURRENT DRUG TARGETS (2012)
Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo
Matt Butler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Adenosine promotes alternative macrophage activation via A2A and A2B receptors
Balazs Csoka et al.
FASEB JOURNAL (2012)
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin et al.
IMMUNITY (2012)
AMP Is an Adenosine A1 Receptor Agonist
Joseph E. Rittiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
Bertrand Allard et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Improvement of drug safety by the use of lipid-based nanocarriers
Sok Bee Lim et al.
JOURNAL OF CONTROLLED RELEASE (2012)
CD73 as a novel prognostic biomarker for human colorectal cancer
Nan Liu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
Xian-Rui Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Lymph node choreography: B cells take the lead
Jennifer L. Cannons et al.
NATURE IMMUNOLOGY (2012)
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase
Rafael Fernandes Zanin et al.
PLOS ONE (2012)
Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
Karen Knapp et al.
STRUCTURE (2012)
CD73: a potent suppressor of antitumor immune responses
Paul. A. Beavis et al.
TRENDS IN IMMUNOLOGY (2012)
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells
Michael Romio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Different role of CD73 in leukocyte trafficking via blood and lymph vessels
Annika Algars et al.
BLOOD (2011)
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
Sara Serra et al.
BLOOD (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-β
Frederico S. Regateiro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
Gennady G. Yegutkin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
Long Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A strategy to deliver genes to cystic fibrosis lungs: A battle with environment
Basma M. Ibrahim et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
NK1.1+ Cells and CD8+ T Cells Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse Melanoma Model
Silvana Morello et al.
NEOPLASIA (2011)
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
K. M. Dwyer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease
Kori L. Wallace et al.
BLOOD (2010)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor
Kengo Moriyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Jinjun Shi et al.
NANO LETTERS (2010)
Engineering nanomedicines for improved melanoma therapy: progress and promises
Di Bei et al.
NANOMEDICINE (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
Parag Aggarwal et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations
Q. Zhoua et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Che-Ming Jack Hu et al.
CURRENT DRUG METABOLISM (2009)
Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39
Matthew C. Hyman et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness
Shannon P. Hilchey et al.
JOURNAL OF IMMUNOLOGY (2009)
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Jean M. Fletcher et al.
JOURNAL OF IMMUNOLOGY (2009)
Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
Rikke Leth-Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Genetic Trickery -- Escape of Leukemia from Immune Attack.
John Barrett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adenosine A2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells
Aftab Ahmad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Extracellular ATP in the Immune System: More Than Just a Danger Signal
Alain Trautmann
SCIENCE SIGNALING (2009)
Protein nanoparticles as drug carriers in clinical medicine
Michael J. Hawkins et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Tenascin C interacts with Ecto-5 '-nucleotidase (eN) and regulates adenosine generation in cancer cells
Rafal Sadej et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
Gennady G. Yegutkin
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
Cyclic AMP in rat ileum: Evidence for the presence of an extracellular cyclic AMP-adenosine pathway
Maria Cecilia Giron et al.
GASTROENTEROLOGY (2008)
CD73 participates in cellular multiresistance program and protects against TRAIL-Induced apoptosis
Andrey Mikhailov et al.
JOURNAL OF IMMUNOLOGY (2008)
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
Jeffrey H. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion
Xiuling Zhi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MCG glioma cell line
Elizandra Braganhol et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates
Liangfang Zhang et al.
CHEMMEDCHEM (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors
Tobias Eckle et al.
CIRCULATION (2007)
Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia
Almut Grenz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
IL-1β and TNF-α regulation of the adenosine receptor (A2A) expression:: differential requirement for NF-κB binding to the proximal promoter
Silvana Morello et al.
JOURNAL OF IMMUNOLOGY (2006)
Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells
Alessandra S. K. Tamajusuku et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells - Involvement of protein kinase A isozyme I (PKA I)
Tatiana Raskovalova et al.
IMMUNOLOGIC RESEARCH (2006)
Expression of ecto-5 '-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma
Rafal Sadej et al.
MELANOMA RESEARCH (2006)
TNF-α upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells:: a basis for A2bR overexpression in colitis
V Kolachala et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Adenosine receptor signaling in the brain immune system
G Haskó et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39
A Papanikolaou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Crucial role for ecto-5-′nucleotidase (CD73) in vascular leakage during hypoxia
LF Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Thyroid hormone upregulates ecto-5′-nucleotidase/CD73 in C6 rat glioma cells
MR Wink et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras
A Grinthal et al.
BIOCHEMISTRY (2002)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage
A Ohta et al.
NATURE (2001)
Mammalian plasma membrane ecto-nucleoside triphosphate diphosphohydrolase 1, CD39, is not active intracellularly -: The N-glycosylation state of CD39 correlates with surface activity and localization
XT Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5 '-nucleotidase along with endogenous ATP from vascular endothelial cells
G Yegutkin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
